JAMEE MCCARTHY: Open Payments
NPI 1447978788 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$642 in 29 payments from 10 companies in 2025. Trend: 2023 $974 · 2024 $605 · 2025 $642
Food & beverage: $642
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $118 |
| Novartis Pharmaceuticals Corporation | 5 | $112 |
| BridgeBio Pharma, Inc. | 5 | $101 |
| Alnylam Pharmaceuticals Inc. | 4 | $93 |
| ABIOMED | 1 | $90 |
| Novo Nordisk Inc | 1 | $33 |
| Amgen Inc. | 2 | $31 |
| Lilly USA, LLC | 2 | $28 |
| PFIZER INC. | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
Products named: LEQVIO, Attruby, AMVUTTRA, WAINUA, Wegovy, REPATHA, MOUNJARO, VYNDAQEL.
Industry payments across CO — which companies pay providers there.
